TechMediaBreaks – SenesTech Inc. (NASDAQ: SNES) Releases Q2 2024 Financial, Corporate Report
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control(R), is reporting on its second-quarter 2024 financial results. According to the report, the company saw record revenue of $874,000 in the first half of 2024, a 62% increase when compared to the first half of 2023, as well as improvement in margin percentages. In addition, the report noted key performance indicators, such as SenesTech’s Evolve(TM) product line, which was launched this year, becoming the company's biggest-selling product line, contributing some 60% revenue this year’s numbers. The report also…